Evaluation of a lyophilized crispr-cas12 assay for a sensitive, specific, and rapid detection of sars-cov-2
Autor: | Cecilia Olguin Perglione, Julia Lara, Carla Alejandra Gimenez, Daiana Macarena Ibáñez Alegre, Melanie Barrios, Federico Alberto Pereyra Bonnet, Ivana Parcerisa, Lucia Ana Curti, Antonela Palacios, Ivana Primost, Adriana Raquel Rinflerch, Débora Natalia Marcone, Guillermo Daniel Repizo, Sofia Valla, María Eugenia Llases |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Serial dilution diagnosis Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Interespaciadas viruses LYSIS BUFFER lcsh:QR1-502 lcsh:Microbiology purl.org/becyt/ford/1 [https] 0302 clinical medicine COVID-19 Testing Nasopharynx Clustered Regularly Interspaced Short Palindromic Repeats 030212 general & internal medicine skin and connective tissue diseases Chemistry Diagnóstico Severe Acute Respiratory Syndrome Coronavirus 2 Respiratory pathogens Infectious Diseases Molecular Diagnostic Techniques CRISPR Fluorescencia RNA Viral Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Loop-mediated isothermal amplification SARS-COV-2 DIAGNOSIS Rapid detection Sensitivity and Specificity Article Fluorescence lysis buffer Liofilización 03 medical and health sciences Virology Lysis buffer Humans purl.org/becyt/ford/1.6 [https] Cycle threshold Chromatography FLUORESCENCE DETECTION SARS-CoV-2 fungi COVID-19 Highly sensitive respiratory tract diseases body regions 030104 developmental biology Freeze Drying fluorescence detection Coronavirus del Síndrome Respiratorio Agudo Grave 2 |
Zdroj: | CONICET Digital (CONICET) Consejo Nacional de Investigaciones Científicas y Técnicas instacron:CONICET Viruses Volume 13 Issue 3 Viruses, Vol 13, Iss 420, p 420 (2021) Viruses 13 (3) : 420 (Marzo 2021) INTA Digital (INTA) Instituto Nacional de Tecnología Agropecuaria instacron:INTA |
Popis: | We evaluated a lyophilized CRISPR-Cas12 assay for SARS-CoV-2 detection (Lyo-CRISPR SARS-CoV-2 kit) based on reverse transcription, isothermal amplification, and CRISPR-Cas12 reaction. From a total of 210 RNA samples extracted from nasopharyngeal swabs using spin columns, the Lyo-CRISPR SARS-CoV-2 kit detected 105/105 (100% 95% confidence interval (CI): 96.55–100) positive samples and 104/105 (99.05% 95% CI: 94.81–99.97) negative samples that were previously tested using commercial RT-qPCR. The estimated overall Kappa index was 0.991, reflecting an almost perfect concordance level between the two diagnostic tests. An initial validation test was also performed on 30 nasopharyngeal samples collected in lysis buffer, in which the Lyo-CRISPR SARS-CoV-2 kit detected 20/21 (95.24% 95% CI: 76.18–99.88) positive samples and 9/9 (100% 95% CI: 66.37–100) negative samples. The estimated Kappa index was 0.923, indicating a strong concordance between the test procedures. The Lyo-CRISPR SARS-CoV-2 kit was suitable for detecting a wide range of RT-qPCR-positive samples (cycle threshold range: 11.45–36.90) and dilutions of heat-inactivated virus (range: 2.5–100 copies/µL) no cross-reaction was observed with the other respiratory pathogens tested. We demonstrated that the performance of the Lyo-CRISPR SARS-CoV-2 kit was similar to that of commercial RT-qPCR, as the former was highly sensitive and specific, timesaving (1.5 h), inexpensive, and did not require sophisticated equipment. The use of this kit would reduce the time taken for diagnosis and facilitate molecular diagnosis in low-resource laboratories. |
Databáze: | OpenAIRE |
Externí odkaz: |